Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perennial vs Preseasonal Allergovit Immunotherapy in Seasonal Allergic Rhinitis
NCT01555736Phase 4Completed
- Sponsor
- Medical University of Lodz
- Start
- Jan 2003
- Primary completion
- Jul 2006
- Modality
- Peptides, Peptide-based Cancer Vaccines, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 4 trial of Allergovit in seasonal allergic rhinitis (SAR), sponsored by Medical University of Lodz. Started Jan 2003; status: completed.
02
Drugs
Allergovit
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01555736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555736.